Delivery Order SPE2DE21D7020-SPE2D625F1HAD
- Not listed
- Boston Scientific Corp, a major global medical technology provider headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $36,734.61 by the Defense Health Agency's Medical Supply Chain on August 15, 2025, with an ultimate completion date of August 22, 2025. The contract, which utilizes economic price adjustment provisions, is classified as contract number 4569107318 and represents a 4mm synthetic material delivery to support the agency's medical supply...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $8,795.18 by the Defense Health Agency's Medical Supply Chain on June 24, 2025. The contract employs fixed-price pricing with economic price adjustment terms and is scheduled for completion by July 1, 2025. The award is not set-aside and represents Boston Scientific's continued role as a prime contractor supplying advanced medical devices to federal...
- Boston Scientific Corp has been awarded a delivery order valued at $2,762.81 by the Defense Health Agency's Medical Supply Chain division, with an ultimate completion date of August 8, 2025. This fixed-price contract with economic price adjustment represents a non-set-aside award to the prime contractor, with performance taking place at Boston Scientific's headquarters in Marlborough, Massachusetts. As a global medical technology company, Boston Scientific provides critical medical devices and...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,303.44 by the Defense Health Agency's Medical Supply Chain program. This fixed-price contract with economic price adjustment, issued on July 28, 2025, is scheduled for completion by August 4, 2025. The award represents a non-set-aside competitive procurement, with performance occurring at Boston Scientific's Marlborough facility. As a...
- Boston Scientific Corp, a Marlborough, Massachusetts-based global medical technology company, was awarded a delivery order by the Defense Health Agency's Medical Supply Chain on July 22, 2025, with an ultimate completion date of July 29, 2025. The contract, valued at $1,727.26, is structured as a fixed price agreement with economic price adjustment provisions and carries no set-aside designation, indicating open competition in the federal marketplace. The award description references medical...
- Boston Scientific Corp, a major global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $32,850 by the Defense Health Agency's Medical Supply Chain under contract 4569047952. This fixed-price delivery order with economic price adjustment terms carries an ultimate completion date of August 18, 2025, and was issued on August 11, 2025. The contract is not set-aside and represents Boston Scientific's continued role as a prime...
- Boston Scientific Corp has been awarded a delivery order valued at $8,128.01 by the Defense Health Agency's Medical Supply Chain program, with an ultimate completion date of August 8, 2025. This fixed-price contract with economic price adjustment provisions represents a task order issued under a larger indefinite delivery vehicle and will be performed at the company's facility in Marlborough, Massachusetts. The contract was awarded competitively with no set-aside designation on August 1, 2025....
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $13,027.08 by the Defense Health Agency's Medical Supply Chain on August 4, 2025. The contract, which utilizes fixed-price pricing with economic price adjustment, is scheduled for completion by August 11, 2025. The award represents a non-set-aside competitive procurement, and the place of performance is Boston Scientific's facility in Marlborough, MA. As...
- Boston Scientific Corp has been awarded a $2,748.80 fixed-price delivery order (Contract No. 4568920509) by the Defense Health Agency's Medical Supply Chain program, with performance to be completed by August 5, 2025. The contract, which carries an economic price adjustment clause, will be performed at the company's Marlborough, Massachusetts location. This delivery order represents Boston Scientific's continued role as a critical supplier of specialized medical devices and equipment to...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $5,050.68 by the Defense Health Agency's Medical Supply Chain program. The contract, issued on August 4, 2025, with an ultimate completion date of August 11, 2025, utilizes fixed-price pricing with economic price adjustment terms and carries no set-aside designation. The place of performance is Boston Scientific's facility in Marlborough,...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F1HADDelivery Order
Boston Scientific Corp has been awarded a delivery order valued at $2,527.50 by the Defense Health Agency's Medical Supply Chain for the supply of 12mm synthetic material medical products. The contract, issued on August 19, 2025, with an ultimate completion date of August 26, 2025, operates under a fixed-price arrangement with economic price adjustment provisions. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts. No set-aside designation was applied to this competitive award, allowing Boston Scientific to compete openly in the federal marketplace alongside other qualified vendors. This delivery order represents a task order under Boston Scientific's broader relationship with the Defense Health Agency, where the company serves as a prime contractor providing specialized medical devices and solutions to federal healthcare agencies. Boston Scientific's extensive portfolio of federal contracts demonstrates its established capability to supply advanced medical technologies, including cardiovascular interventions, stents, and other specialized medical equipment to defense and civilian federal healthcare systems. The company's role as a critical supplier within the federal medical supply chain underscores its strategic importance in supporting healthcare delivery across the Department of Defense and related agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 8/19/25 |